Tidepath

Repair and recovery peptides

TB-500

Also called Thymosin beta-4 fragment

A small piece of a protein, easily mistaken for the whole thing.

Status
Not approved by the FDA.
Routes we have on file
By injection or by injection into muscle
Where doses come from
No checked dose range
Half-life
No measured half-life in people for the TB-500 fragment in our sources

What it is

TB-500 is LKKTETQ, a chain of seven amino acids (each letter stands for one), and a short piece of a larger protein called thymosin beta-4. It isn't the whole protein, so studies of the whole protein in people can't be assumed to apply to TB-500.

What makes it distinct

The mix-up is the story. There are studies of whole thymosin beta-4 in people. They're studies of a different molecule, and human studies haven't proven they apply to TB-500. Our sources record that the FDA found no data on people taking drug products that contain this fragment. It also says compounded TB-500 (mixed from its ingredients by a pharmacist or doctor) given certain ways may carry a risk of immune reactions (immunogenicity), because of the potential for the peptide to clump together (aggregation) and for impurities related to it.

Open questions

  • Whether results for whole thymosin beta-4 tell us anything about the fragment. Human studies haven't proven that they do.
  • How long it lasts in the body (pharmacokinetics). We found no measured half-life (the time it takes for half a dose to clear) for TB-500 in people. Tidepath doesn't chart its levels.

Worth knowing

If something you read about TB-500 cites thymosin beta-4 research without telling the two apart, that's worth noticing. It's how one molecule borrows another's evidence.

More in Repair and recovery peptides